USD 12.11 Billion
Global Stem Cell Therapy Market Size, Share, Growth Analysis, By Therapy(Autologous, and Allogenic), By Application(Neurological Disorders, Orthopedic Treatments) - Industry Forecast 2024-2031
Report ID:
SQMIG35H2162 |
Region:
Global |
Published Date: March, 2024
Pages:
219
|
Tables:
65 |
Figures:
75
Global Stem Cell Therapy Market Insights
Global Stem Cell Therapy Market size was valued at USD 12.11 Billion in 2022 and is poised to grow from USD 13.33 Billion in 2023 to USD 28.79 Billion by 2031, at a CAGR of 10.1% during the forecast period (2024-2031).
The primary purpose of the stem cell therapy market is to provide innovative treatment options for a wide range of medical conditions. Stem cell therapies aim to address diseases and injuries that have limited or no effective treatment options currently available. By harnessing the regenerative properties of stem cells, this market seeks to offer hope to patients suffering from conditions such as cardiovascular diseases, neurodegenerative disorders, orthopedic injuries, autoimmune diseases, and certain types of cancer. the growth of the global stem cell therapy market. One of the key drivers is the increasing prevalence of chronic diseases and age-related conditions.
One of the primary challenges is the high cost associated with stem cell therapies. The stem cell therapy market faces several challenges. One of the key challenges is the need for standardization and regulation. As stem cell therapies evolve, it becomes essential to establish clear guidelines and standards for their development, manufacturing, and clinical application. The market faces challenges related to scalability and cost-effectiveness. Scaling up the production of stem cell therapies to meet the demand while maintaining quality and reducing costs remains a significant hurdle. the challenges, the stem cell therapy market offers significant opportunities. The expanding pipeline of clinical trials and research studies exploring the potential of stem cell therapies indicates a promising future.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Allogenic
Fastest Growth
Allogenic
Growth Rate
10.1% CAGR
Global Stem Cell Therapy Market 2022-2030 ($ Bn)
Country Share for North America Region- 2022 (%)
Global Stem Cell Therapy Market Size By Therapy, 2022-2030 ($ Bn)
Global Stem Cell Therapy Market Size By Therapy, 2022-2030 (%)
To get more reports on the above market click here to Buy The Report
Global Stem Cell Therapy Market Segmental Analysis
The global stem cell therapy market is segmented on the therapy, application, and region. In terms of therapy, the market is segmented into autologous, and allogeneic. With respect to classification by application, the market is segmented into Neurological Disorders, Orthopedic Treatments, Oncology Disorders, Injuries and Wounds, Cardiovascular Disorders, and Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Stem Cell Therapy Market Analysis by Therapy
In 2022, the allogeneic therapy segment dominated the stem cell therapy market. capturing a significant market share of 59.14% in terms of revenue generation. This growth can be attributed to factors such as higher pricing of allogeneic therapies and the increasing popularity of stem cell banking. Many companies in the cell therapy sector are focusing on developing allogeneic cell therapy products, further contributing to the growth of this segment. strategic initiatives by key market players aimed at strengthening their product portfolios are expected to create lucrative opportunities during the review period. For example, Acepodia secured USD 47 million in Series B financing in March 2021 to advance its pipeline of allogeneic cell therapy candidates. Additionally, Immatics and Bristol Myers Squibb expanded their strategic alliance in June 2022 to develop gamma delta allogeneic cell therapy programs.
The autologous therapy segment is projected to witness substantial growth throughout the forecast period. This is primarily due to the lower risk of complications associated with autologous treatments. Other factors driving the growth of this segment include affordability, improved patient survival rates, the absence of the need to identify an HLA-matched donor, and a reduced risk of graft-versus-host diseases. Autologous mesenchymal stem cells (MSCs) are also being investigated for their potential in treating osteoarthritis, as they can differentiate into cartilage and bone tissues.
Global Stem Cell Therapy Market Analysis by Application
Neurological Disorders Stands as the largest segment, captivating both researchers and patients alike with its transformative possibilities. these developments above reveal how stem cells therapy have greatly impacted upon managing disorders such as Parkinson's, Alzheimer's and spinal cord injuries Stem cell treatment provides an essential relief for millions people pursuing a comprehensive solution beyond a simple symptomatic treatment and even a ‘regeneration’ and ‘restoration’ of neural function. As the world is facing this surge in aging population, the treatment of neurological disorders becomes increasingly important; the investment increases and the research is in phenomena of the age of intellectual advancement and new discoveries is initiated in this area.
Oncology Disorders is the fastest growing segment in this market. In order to explain the development of cancer cells in this universe, this realm of stem cell therapy which is experiencing an explosive escalation due to its mission to change the set of rules of cancer treatment. Stem cells may be incrementally stepping into the role of "personalized, targeted therapies" employing the approach of exact tumor localization and restoration of healthy tissues after the treatment. As cancer stalks the world without a touch of mercy, fostering stem-cell-based innovations gains increased traction in the medical spectrum, bringing this segment at the prime of the medical frontier. With each breakthrough, the boundaries of what's possible in cancer care blur, underscoring the profound impact of stem cell therapy on the oncological landscape.
Global Stem Cell Therapy Market Size By Therapy, 2022(%), 2022 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Stem Cell Therapy Market Regional Insights
In 2022, North America dominated the stem cell therapy market with the largest revenue share of 44.56%. This can be attributed to several factors, including the presence of innovative companies and key market players in the region, leading to a higher penetration of stem cell therapy products. North America is known for its strong biotechnology industry, extensive research and development activities, and a focus on promoting personalized medicines. These factors contribute to the region's leading position in the market. Additionally, the growth in North America is further supported by government initiatives aimed at promoting stem cell therapies.
Asia Pacific is expected to exhibit rapid growth in the stem cell therapy market, with a projected compound annual growth rate (CAGR) of 16.09% during the period of 2023-2030. This growth is driven by factors such as strong product pipelines of stem cell-based therapies and a large patient population base in the region. The incidence rate of diseases like cancer, neurological disorders, and diabetes is increasing, creating a demand for advanced treatments such as stem cell therapies. Furthermore, governments in the Asia Pacific region are actively funding and supporting stem cell research to accelerate advancements in the field.
Global Stem Cell Therapy Market Size By Geography, 2022-2030, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Stem Cell Therapy Market Dynamics
Global Stem Cell Therapy Market Drivers
Increasing Prevalence of Chronic Diseases
- The rising burden of chronic diseases, such as cardiovascular disorders, neurodegenerative conditions, and orthopedic injuries, is a significant driver for the stem cell therapy market. Stem cell therapies offer the potential to regenerate damaged tissues and organs, providing new treatment options for patients with limited or no effective alternatives.
Technological Advancements and Research Investments
- Advances in stem cell research and technologies have expanded the understanding of stem cells and their applications. The development of novel methods for cell isolation, expansion, and differentiation, as well as genetic engineering techniques, have propelled the field forward. Increased investments in stem cell research by governments, academic institutions, and private companies have accelerated the pace of innovation.
Global Stem Cell Therapy Market Restraints
High Treatment Costs
- The high cost associated with stem cell therapies poses a significant barrier to widespread adoption. The research and development efforts, manufacturing complexities, and regulatory requirements contribute to the high price of these therapies. This limits access to stem cell treatments for many patients, particularly in lower-income regions.
Ethical and Regulatory Challenges
- The ethical considerations surrounding the use of certain types of stem cells, such as embryonic stem cells, have limited their widespread acceptance and funding. Additionally, navigating the regulatory landscape and ensuring compliance with various regulations for clinical trials and commercialization of stem cell therapies can be complex and time-consuming.
Request Free Customization of this report to help us to meet your business objectives.
Global Stem Cell Therapy Market Competitive Landscape
The Global Stem cell therapy Market is highly competitive, with several key players operating in the industry. These companies are actively involved in research and development, strategic collaborations, mergers and acquisitions, and product launches to gain a competitive edge in the market. Here are some prominent players in the stem cell therapy market. The market is dynamic and competitive, with ongoing advancements and new entrants continually shaping the landscape. It is worth noting that the competitive landscape may evolve over time as companies pursue strategic collaborations, expand their product portfolios, and introduce new therapies to address unmet medical needs.
Top Player’s Company Profiles in Global Stem Cell Therapy Market
- Novartis AG (Switzerland)
- Pfizer Inc. (US)
- Mesoblast Limited (Australia)
- Celgene Corporation (a subsidiary of Bristol Myers Squibb) (US)
- TiGenix NV (a subsidiary of Takeda Pharmaceutical Company Limited) (Belgium)
- Gamida Cell Ltd. (Israel)
- Vericel Corporation (US)
- Medipost Co., Ltd. (South Korea)
- Astellas Pharma Inc. (Japan)
- Osiris Therapeutics, Inc. (US)
- NuVasive, Inc. (US)
- Cynata Therapeutics Limited (Australia)
- Cellular Dynamics International (a subsidiary of FUJIFILM Holdings Corporation) (US)
- Lonza Group Ltd. (Switzerland)
- Caladrius Biosciences, Inc. (US)
- Athersys, Inc. (US)
- Cytori Therapeutics, Inc. (US)
- Holostem Terapie Avanzate S.r.l. (Italy)
- Pluristem Therapeutics Inc. (Israel)
- BioTime, Inc. (US)
Global Stem Cell Therapy Market Recent Developments
-
In December 2023 to create cellular treatment goods, services, and testing, GenCure and the University of Texas at San Antonio (UTSA) partnered.
-
A contract for the research, development, and production of iPSC-derived regulatory T cells (Tregs) with potential therapeutic applications was signed in August 2023 by BlueRock Therapeutics LP and bit.bio.
-
In July 2023, PromoCell GmbH introduced the PromoExQ MSC Growth Medium XF, which enables the consistent growth and maintenance of multipotent human mesenchymal stem cells (hMSCs) in vitro within a controlled environment.
-
Pluristyx, Inc. and Stem Genomics collaborated in July 2023. Through this collaboration, the Stem Genomics iCS-digital PSC assay will be used to assess the genomic stability of Pluristyx's pluripotent stem cell (PSC) lines.
-
June of 2023 The human induced pluripotent stem cell (iPSC) producer, FUJIFILM Cellular Dynamics, has announced the release of their iCell Blood-Brain Barrier Isogenic Kit, designed for scientists who are involved in the drug development process for neuroactive pharmaceuticals. The kit can improve medication development, discovery, and medical research for disorders of the central nervous system (CNS) since it maintains barrier integrity.
Global Stem Cell Therapy Key Market Trends
- Increased Focus on Allogeneic Therapies: Allogeneic stem cell therapies, which use cells from a donor, have gained traction in the market. This approach offers advantages such as standardized and readily available cell sources, reduced manufacturing costs, and potential off-the-shelf treatments. Many companies are shifting their focus towards developing allogeneic cell therapy products, leading to an expanding pipeline of clinical trials and product development in this area.
- Personalized Medicine and Cell Banking: Personalized medicine, tailoring treatments to individual patients based on their unique characteristics, is gaining prominence in the stem cell therapy market. Cell banking, including the collection and storage of patients' own cells for future therapeutic use, is becoming increasingly important. This approach enables personalized and timely treatment options, particularly in autologous therapies, where a patient's own cells are used.
Global Stem Cell Therapy Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analyses, the global stem cell therapy market is expected to be driven by the rising prevalence of chronic diseases, increasing investment in stem cell research, and growing demand for regenerative medicine. The market growth is driven by several factors, including the increasing prevalence of chronic diseases, growing investment in stem cell research and development, advancements in stem cell technologies, and rising government support for stem cell therapies. The global stem cell therapy market is highly competitive with the presence of several players. The government of India set up state-of-the-art stem cell research facilities in 40 leading health research and educational institutions, which is expected to accelerate research in the field.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 12.11 Billion |
| Market size value in 2031 | USD 28.79 Billion |
| Growth Rate | 10.1% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Stem Cell Therapy Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Stem Cell Therapy Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Stem Cell Therapy Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Stem Cell Therapy Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Stem Cell Therapy Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Stem Cell Therapy Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Stem Cell Therapy Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
